Zoungas S, Curtis A, Spark S, et al. Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial). BMJ Open. 2023;13(4): e069915. https://doi.org/10.1136/bmjopen-2022-069915.

Article  PubMed  PubMed Central  Google Scholar 

Orkaby AR, Driver JA, Ho YL, et al. Association of statin use with all-cause and cardiovascular mortality in US Veterans 75 years and older. JAMA. 2020;324(1):68–78. https://doi.org/10.1001/jama.2020.7848.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603. https://doi.org/10.1161/CIR.0000000000000485.

Article  PubMed  PubMed Central  Google Scholar 

Hawley CE, Roefaro J, Forman DE, Orkaby AR. Statins for primary prevention in those aged 70 years and older: a critical review of recent cholesterol guidelines. Drugs Aging. 2019;36(8):687–99. https://doi.org/10.1007/s40266-019-00673-w.

Article  PubMed  PubMed Central  Google Scholar 

Singh S, Zieman S, Go AS, et al. Statins for primary prevention in older adults-moving toward evidence-based decision-making. J Am Geriatr Soc. 2018;66(11):2188–96. https://doi.org/10.1111/jgs.15449.

Article  PubMed  PubMed Central  Google Scholar 

Afilalo J. Frailty in patients with cardiovascular disease: why, when, and how to measure. Curr Cardiovasc Risk Rep. 2011;5(5):467–72. https://doi.org/10.1007/s12170-011-0186-0.

Article  PubMed  PubMed Central  Google Scholar 

Damluji AA, Chung SE, Xue QL, et al. Frailty and cardiovascular outcomes in the National Health and Aging Trends Study. Eur Heart J. 2021;42(37):3856–65. https://doi.org/10.1093/eurheartj/ehab468.

Article  PubMed  PubMed Central  Google Scholar 

He D, Wang Z, Li J, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024. https://doi.org/10.1093/eurheartj/ehad885.

Article  PubMed  PubMed Central  Google Scholar 

Armitage J, Baigent C, Barnes E, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393(10170):407–15. https://doi.org/10.1016/S0140-6736(18)31942-1.

Article  Google Scholar 

Foody JM, Rathore SS, Galusha D, et al. Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction. J Am Geriatr Soc. 2006;54(3):421–30. https://doi.org/10.1111/j.1532-5415.2005.00635.x.

Article  PubMed  PubMed Central  Google Scholar 

Damluji AA, Chung SE, Xue QL, et al. Physical frailty phenotype and the development of geriatric syndromes in older adults with coronary heart disease. Am J Med. 2021;134(5):662-671.e1. https://doi.org/10.1016/j.amjmed.2020.09.057.

Article  PubMed  Google Scholar 

Odden MC, Pletcher MJ, Coxson PG, et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med. 2015;162(8):533–41. https://doi.org/10.7326/M14-1430.

Article  PubMed  PubMed Central  Google Scholar 

Ravnskov U, Diamond DM, Hama R, et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open. 2016;6(6): e010401. https://doi.org/10.1136/bmjopen-2015-010401.

Article  PubMed  PubMed Central  Google Scholar 

Silverman MG, Ference BA, Im K, et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA. 2016;316(12):1289–97. https://doi.org/10.1001/jama.2016.13985.

Article  PubMed  CAS  Google Scholar 

Sittiwet C, Simonen P, Gylling H, Strandberg TE. Mortality and cholesterol metabolism in subjects aged 75 years and older: the helsinki businessmen study. J Am Geriatr Soc. 2020;68(2):281–7. https://doi.org/10.1111/jgs.16305.

Article  PubMed  Google Scholar 

Maihofer AX, Shadyab AH, Wild RA, LaCroix AZ. Associations between serum levels of cholesterol and survival to age 90 in postmenopausal women. J Am Geriatr Soc. 2020;68(2):288–96. https://doi.org/10.1111/jgs.16306.

Article  PubMed  Google Scholar 

Orkaby AR. The highs and lows of cholesterol: a paradox of healthy aging? J Am Geriatr Soc. 2020;68(2):236–7. https://doi.org/10.1111/jgs.16302.

Article  PubMed  Google Scholar 

Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644–52. https://doi.org/10.1016/S0140-6736(20)32233-9.

Article  PubMed  CAS  Google Scholar 

Andersson NW, Corn G, Dohlmann TL, Melbye M, Wohlfahrt J, Lund M. LDL-C reduction with lipid-lowering therapy for primary prevention of major vascular events among older individuals. J Am Coll Cardiol. 2023;82(14):1381–91. https://doi.org/10.1016/j.jacc.2023.07.027.

Article  PubMed  CAS  Google Scholar 

Park CS, Yang HM, Han K, et al. J-shaped association between LDL cholesterol and cardiovascular events: a longitudinal primary prevention cohort of over 2.4 million people nationwide. J Adv Res. 2023. https://doi.org/10.1016/j.jare.2023.05.003.

Article  PubMed  PubMed Central  Google Scholar 

Joseph J, Pajewski NM, Dolor RJ, et al. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale. J Am Geriatr Soc. 2023;71(6):1701–13. https://doi.org/10.1111/jgs.18312.

Article  PubMed  PubMed Central  Google Scholar 

Dalton JE, Rothberg MB, Dawson NV, Krieger NI, Zidar DA, Perzynski AT. Failure of traditional risk factors to adequately predict cardiovascular events in older populations. J Am Geriatr Soc. 2020;68(4):754–61. https://doi.org/10.1111/jgs.16329.

Article  PubMed  PubMed Central  Google Scholar 

Group Sw, collaboration ESCCr. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–2454. https://doi.org/10.1093/eurheartj/ehab309.

Nanna MG, Peterson ED, Wojdyla D, Navar AM. The accuracy of cardiovascular pooled cohort risk estimates in U.S. older adults. J Gen Intern Med. 2020;35(6):1701–8. https://doi.org/10.1007/s11606-019-05361-4.

Article  PubMed  Google Scholar 

Khan SS, Matsushita K, Sang Y, et al. Development and validation of the american heart association’s PREVENT equations. Circulation. 2024;149(6):430–49. https://doi.org/10.1161/CIRCULATIONAHA.123.067626.

Article  PubMed  Google Scholar 

Yourman LC, Cenzer IS, Boscardin WJ, et al. Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years: a meta-analysis. JAMA Intern Med. 2021;181(2):179–85. https://doi.org/10.1001/jamainternmed.2020.6084.

Article  PubMed  CAS  Google Scholar 

Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50–8. https://doi.org/10.1001/jama.2010.1923.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Orkaby AR, Rich MW. Cardiovascular screening and primary prevention in older adults. Clin Geriatr Med. 2018;34(1):81–93. https://doi.org/10.1016/j.cger.2017.08.003.

Article  PubMed  Google Scholar 

Sheppard JP, Lakshmanan S, Lichtenstein SJ, Budoff MJ, Roy SK. Age and the power of zero CAC in cardiac risk assessment: overview of the literature and a cautionary case. Br J Cardiol. 2022;29(3):23. https://doi.org/10.5837/bjc.2022.023.

Article  PubMed